Naveed Sattar

Naveed Sattar

University of Glasgow

H-index: 207

Europe-United Kingdom

About Naveed Sattar

Naveed Sattar, With an exceptional h-index of 207 and a recent h-index of 147 (since 2020), a distinguished researcher at University of Glasgow, specializes in the field of metabolism, lipids, diabetes, cardiovascular disease, biomarkers.

His recent articles reflect a diverse array of research interests and contributions to the field:

Non-coronary arterial outcomes in people with type 1 diabetes mellitus: a Swedish retrospective cohort study

Effects of statin therapy on diagnoses of new-onset diabetes and worsening glycaemia in large-scale randomised blinded statin trials: an individual participant data meta-analysis

2023 ESC Guidelines for the management of endocarditis

Baseline characteristics in the Remote Diet Intervention to Reduce long-COVID symptoms Trial (ReDIRECT)

Cardiovascular and renal outcomes with varying degrees of kidney disease in high‐risk people with type 2 diabetes: An epidemiological analysis of data from the AMPLITUDE‐O trial

Carbohydrate antigen 125 concentrations across the ejection fraction spectrum in chronic heart failure: The EMPEROR programme

Effects of long-term HbA1c variability on serious infection risks in patients with type 2 diabetes and the influence of age, sex and ethnicity: A cohort study of primary care data

Genetic drivers of heterogeneity in type 2 diabetes pathophysiology

Naveed Sattar Information

University

Position

___

Citations(all)

237576

Citations(since 2020)

134333

Cited By

136476

hIndex(all)

207

hIndex(since 2020)

147

i10Index(all)

1135

i10Index(since 2020)

960

Email

University Profile Page

Google Scholar

Naveed Sattar Skills & Research Interests

metabolism

lipids

diabetes

cardiovascular disease

biomarkers

Top articles of Naveed Sattar

Non-coronary arterial outcomes in people with type 1 diabetes mellitus: a Swedish retrospective cohort study

The Lancet Regional Health–Europe

2024/4/1

2023 ESC Guidelines for the management of endocarditis

2023/10/14

Baseline characteristics in the Remote Diet Intervention to Reduce long-COVID symptoms Trial (ReDIRECT)

NIHR Open Research

2024/3/5

Cardiovascular and renal outcomes with varying degrees of kidney disease in high‐risk people with type 2 diabetes: An epidemiological analysis of data from the AMPLITUDE‐O trial

Diabetes, Obesity and Metabolism

2024/4

Naveed Sattar
Naveed Sattar

H-Index: 125

Carbohydrate antigen 125 concentrations across the ejection fraction spectrum in chronic heart failure: The EMPEROR programme

European Journal of Heart Failure

2024/3/4

Effects of long-term HbA1c variability on serious infection risks in patients with type 2 diabetes and the influence of age, sex and ethnicity: A cohort study of primary care data

Diabetes Research and Clinical Practice

2024/5/1

Naveed Sattar
Naveed Sattar

H-Index: 125

Worth Their Weight? An Update on New and Emerging Pharmacologic Agents for Obesity and Their Potential Role for Persons with Cardiac Conditions

2024/3/29

New insights into understanding obesity: from measures to mechanisms

2024/3/1

Naveed Sattar
Naveed Sattar

H-Index: 125

Preclinical Modeling of Metabolic Syndrome to Study the Pleiotropic Effects of Novel Antidiabetic Therapy Independent of Obesity

2024/4/22

Impact of Residential Social Deprivation on Prediction of Heart Failure in Patients With Type 2 Diabetes: External Validation and Recalibration of the WATCH-DM Score Using Real …

Circulation: Cardiovascular Quality and Outcomes

2024/2/8

Reflecting on a Year at the Helm of Diabetes Care

2024/1/1

The association between county-level premature cardiovascular mortality related to cardio-kidney-metabolic disease and the social determinants of health in the US

2024/3/27

Natriuretic Peptides and Prognosis in Patients with Type 2 Diabetes Mellitus and High Risk for Cardiovascular Events

Journal of Cardiac Failure

2024/4/16

Genetic evidence for distinct biological mechanisms that link adiposity to type 2 diabetes: towards precision medicine

Diabetes

2024/3/26

Growth differentiation factor‐15 and the effect of empagliflozin in heart failure: Findings from the EMPEROR program

European Journal of Heart Failure

2024/1

Impact of weight loss on cancer-related proteins in serum: results from a cluster randomised controlled trial of individuals with type 2 diabetes

EBioMedicine

2024/2/1

Defining metabolically healthy and unhealthy obesity in relation to cancer risk: A prospective cohort study by using a machine learning approach in comparison with conventional …

Cancer Research

2024/3/22

Putting More Weight on Obesity Trials in Heart Failure

2024/4/15

See List of Professors in Naveed Sattar University(University of Glasgow)

Co-Authors

academic-engine